162 related articles for article (PubMed ID: 17576332)
1. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR.
Cho-Vega JH; Vega F; Schwartz MR; Prieto VG
J Cutan Pathol; 2007 Jul; 34(7):535-42. PubMed ID: 17576332
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
Silye R; Karayiannakis AJ; Syrigos KN; Poole S; van Noorden S; Batchelor W; Regele H; Sega W; Boesmueller H; Krausz T; Pignatelli M
J Pathol; 1998 Dec; 186(4):350-5. PubMed ID: 10209482
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
[TBL] [Abstract][Full Text] [Related]
4. Cell adhesion and communication proteins are differentially expressed in melanoma progression model.
Rezze GG; Fregnani JH; Duprat J; Landman G
Hum Pathol; 2011 Mar; 42(3):409-18. PubMed ID: 21193224
[TBL] [Abstract][Full Text] [Related]
5. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
Cohn ML; Goncharuk VN; Diwan AH; Zhang PS; Shen SS; Prieto VG
J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
[TBL] [Abstract][Full Text] [Related]
6. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis.
Pećina-Slaus N; Zigmund M; Kusec V; Martić TN; Cacić M; Slaus M
J Cutan Pathol; 2007 Mar; 34(3):239-46. PubMed ID: 17302608
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
Prieto VG; Mourad-Zeidan AA; Melnikova V; Johnson MM; Lopez A; Diwan AH; Lazar AJ; Shen SS; Zhang PS; Reed JA; Gershenwald JE; Raz A; Bar-Eli M
Clin Cancer Res; 2006 Nov; 12(22):6709-15. PubMed ID: 17121890
[TBL] [Abstract][Full Text] [Related]
9. Adhesion molecule profile and malignancy of melanocytic lesions.
Moretti S; Martini L; Berti E; Pinzi C; Giannotti B
Melanoma Res; 1993 Aug; 3(4):235-9. PubMed ID: 8219755
[TBL] [Abstract][Full Text] [Related]
10. Subtypes of melanocytes and melanoma cells distinguished by their intercellular contacts: heterotypic adherens junctions, adhesive associations, and dispersed desmoglein 2 glycoproteins.
Rickelt S; Franke WW; Doerflinger Y; Goerdt S; Brandner JM; Peitsch WK
Cell Tissue Res; 2008 Dec; 334(3):401-22. PubMed ID: 18975006
[TBL] [Abstract][Full Text] [Related]
11. Roles of E- and P-cadherin in the human skin.
Furukawa F; Fujii K; Horiguchi Y; Matsuyoshi N; Fujita M; Toda K; Imamura S; Wakita H; Shirahama S; Takigawa M
Microsc Res Tech; 1997 Aug; 38(4):343-52. PubMed ID: 9297684
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression in melanocytic lesions of the skin.
Ramirez JA; Guitart J; Rao MS; Diaz LK
Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
[TBL] [Abstract][Full Text] [Related]
13. Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome.
Flørenes VA; Maelandsmo GM; Holm R; Reich R; Lazarovici P; Davidson B
Am J Clin Pathol; 2004 Sep; 122(3):412-20. PubMed ID: 15362372
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of cyclooxygenage-2 in melanocytic skin lesions.
Minami S; Lum CA; Kitagawa KM; Namiki TS
Int J Dermatol; 2011 Jan; 50(1):24-9. PubMed ID: 21182498
[TBL] [Abstract][Full Text] [Related]
15. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Fullen DR; Zhu W; Thomas D; Su LD
J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
[TBL] [Abstract][Full Text] [Related]
16. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
17. Expression of intercellular adhesion molecule-1 (ICAM-1) in benign naevi and malignant melanomas.
Hansen NL; Ralfkiaer E; Hou-Jensen K; Thomsen K; Drzewiecki KT; Rothlein R; Vejlsgaard GL
Acta Derm Venereol; 1991; 71(1):48-51. PubMed ID: 1676215
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion protein expression in melanocytic matricoma.
Soler AP; Burchette JL; Bellet JS; Olson JA
J Cutan Pathol; 2007 Jun; 34(6):456-60. PubMed ID: 17518772
[TBL] [Abstract][Full Text] [Related]
19. Markers of melanocytic tumour progression.
Ruiter DJ; van Muijen GN
J Pathol; 1998 Dec; 186(4):340-2. PubMed ID: 10209480
[TBL] [Abstract][Full Text] [Related]
20. Cadherin expression in melanocytic naevi and malignant melanomas.
Cowley GP; Smith ME
J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]